home / stock / mrna / mrna quote
Last: | $122.205 |
---|---|
Change Percent: | 0.88% |
Open: | $122.52 |
Close: | $121.14 |
High: | $124.055 |
Low: | $120.44 |
Volume: | 842,446 |
Last Trade Date Time: | 07/22/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$122.205 | $122.52 | $121.14 | $124.055 | $120.44 | 842,446 | 07-22-2024 |
$121.14 | $121.01 | $121.14 | $121.9799 | $118.8 | 2,202,667 | 07-19-2024 |
$121.32 | $124.1 | $121.32 | $126.4199 | $121 | 2,018,271 | 07-18-2024 |
$124.055 | $123.12 | $124.055 | $125.32 | $120.11 | 2,851,241 | 07-17-2024 |
$125.14 | $122.76 | $125.14 | $127.2 | $120.79 | 3,008,616 | 07-16-2024 |
$121.48 | $121.1 | $121.48 | $121.94 | $116 | 2,682,201 | 07-15-2024 |
$121.46 | $123.68 | $121.46 | $129.39 | $121.01 | 4,526,238 | 07-12-2024 |
$122.82 | $120.03 | $122.82 | $124.19 | $119.39 | 4,164,814 | 07-11-2024 |
$117.44 | $116.1 | $117.44 | $120.378 | $115.29 | 2,820,093 | 07-10-2024 |
$116.07 | $116.71 | $116.07 | $118.84 | $115.4 | 2,512,265 | 07-09-2024 |
$116.45 | $118.41 | $116.45 | $119.3 | $115.56 | 2,195,485 | 07-08-2024 |
$118.32 | $117.3 | $118.32 | $118.88 | $115.7 | 3,067,183 | 07-05-2024 |
$115.95 | $118.74 | $115.95 | $119.39 | $115.3 | 1,853,449 | 07-04-2024 |
$115.95 | $118.74 | $115.95 | $119.39 | $115.3 | 1,853,449 | 07-03-2024 |
$117.07 | $117.34 | $117.07 | $119.14 | $114.02 | 3,425,779 | 07-02-2024 |
$115.95 | $117.05 | $115.95 | $123.74 | $115.1401 | 3,724,162 | 07-01-2024 |
$118.75 | $122.59 | $118.75 | $123.2499 | $118.03 | 3,976,313 | 06-28-2024 |
$121.18 | $121.9 | $121.18 | $122.2799 | $118.52 | 4,804,225 | 06-27-2024 |
$122.45 | $135.17 | $122.45 | $135.37 | $122.12 | 7,721,615 | 06-26-2024 |
$137.6 | $136 | $137.6 | $138.07 | $134.73 | 3,387,262 | 06-25-2024 |
News, Short Squeeze, Breakout and More Instantly...
CAMBRIDGE, MA / ACCESSWIRE / July 10, 2024 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, August 1, 2024 to report its second quarter 2024 financial results, and provide a corporate update. A live webcast of the c...
CAMBRIDGE, MA AND OSAKA, JAPAN / ACCESSWIRE / July 8, 2024 / Moderna, Inc. (Nasdaq:MRNA) and Mitsubishi Tanabe Pharma Corporation today announced that the companies have entered into a joint agreement regarding the co-promotion of Moderna's mRNA respiratory vaccine portfolio in Japan, including ...
CAMBRIDGE, MA / ACCESSWIRE / July 2, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced a project award of $176 million through the Rapid Response Partnership Vehicle (RRPV) to accelerate the development of mRNA-based pandemic influenza vaccines. The RRPV is a Consortium funded by the Biomedical...